Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A O'Neill

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
FEBS Letters|October 10, 1994
Molecular mechanisms of damage by excess nitrogen oxides: nitration of tyrosine by gas-phase cigarette smokeJ P Eiserich, V Vossen, C A O'Neill, et al.
Annals of the New York Academy of Sciences|May 28, 1993
Cigarette smoke oxidation of human plasma constituentsC E Cross, C A O'Neill, A Z Reznick, et al.
Developmental Biology|May 21, 2013
Rab3Gap1 mediates exocytosis of Claudin-1 and tight junction formation during epidermal barrier acquisitionG Youssef, L Gerner, A S Naeem, et al.
Biochemical Society Symposium|January 1, 1995
Oxidative damage by ozone and nitrogen dioxide: synergistic toxicity in vivo but no evidence of synergistic oxidative damage in an extracellular fluidC A O'Neill, A van der Vliet, J P Eiserich, et al.
Acta Paediatrica (Oslo, Norway : 1992). Supplement|December 1, 1994
Molecular analysis of PKU in IrelandC A O'Neill, R C Eisensmith, D T Croke, et al.
The Biochemical Journal|October 1, 1994
Interactions of peroxynitrite with human plasma and its constituents: oxidative damage and antioxidant depletionA Van der Vliet, D Smith, C A O'Neill, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1993
Oxidation of biologic molecules by ozone: the effect of pHC A O'Neill, A van der Vliet, M L Hu, et al.
The American Journal of Physiology|February 10, 1999
Determination of low-molecular-mass antioxidant concentrations in human respiratory tract lining fluidsA van der Vliet, C A O'Neill, C E Cross, et al.
The Journal of Pathology|June 22, 2007
Altered claudin expression is a feature of chronic plaque psoriasisR E B Watson, R Poddar, J M Walker, et al.
Toxicologic Pathology|June 15, 1999
Preclinical safety evaluation of rhuMAbVEGF, an antiangiogenic humanized monoclonal antibodyA M Ryan, D B Eppler, K E Hagler, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
FEBS Letters|October 10, 1994
Molecular mechanisms of damage by excess nitrogen oxides: nitration of tyrosine by gas-phase cigarette smokeJ P Eiserich, V Vossen, C A O'Neill, et al.
Annals of the New York Academy of Sciences|May 28, 1993
Cigarette smoke oxidation of human plasma constituentsC E Cross, C A O'Neill, A Z Reznick, et al.
Developmental Biology|May 21, 2013
Rab3Gap1 mediates exocytosis of Claudin-1 and tight junction formation during epidermal barrier acquisitionG Youssef, L Gerner, A S Naeem, et al.
Biochemical Society Symposium|January 1, 1995
Oxidative damage by ozone and nitrogen dioxide: synergistic toxicity in vivo but no evidence of synergistic oxidative damage in an extracellular fluidC A O'Neill, A van der Vliet, J P Eiserich, et al.
Acta Paediatrica (Oslo, Norway : 1992). Supplement|December 1, 1994
Molecular analysis of PKU in IrelandC A O'Neill, R C Eisensmith, D T Croke, et al.
The Biochemical Journal|October 1, 1994
Interactions of peroxynitrite with human plasma and its constituents: oxidative damage and antioxidant depletionA Van der Vliet, D Smith, C A O'Neill, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1993
Oxidation of biologic molecules by ozone: the effect of pHC A O'Neill, A van der Vliet, M L Hu, et al.
The American Journal of Physiology|February 10, 1999
Determination of low-molecular-mass antioxidant concentrations in human respiratory tract lining fluidsA van der Vliet, C A O'Neill, C E Cross, et al.
The Journal of Pathology|June 22, 2007
Altered claudin expression is a feature of chronic plaque psoriasisR E B Watson, R Poddar, J M Walker, et al.
Toxicologic Pathology|June 15, 1999
Preclinical safety evaluation of rhuMAbVEGF, an antiangiogenic humanized monoclonal antibodyA M Ryan, D B Eppler, K E Hagler, et al.
Pageof 4